ESGU vs IBB
iShares MSCI USA ESG Optimized ETF vs iShares Biotechnology ETF
- • ESGU has the lower expense ratio at 0.15% vs 0.44% for IBB.
- • ESGU pays a higher dividend yield (0.94%).
Side-by-side metrics
| Metric | ESGU | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.94% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $17.75B | $9.09B |
YTD return | 10.32% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 0.69 |
P/E ratio | 27.11 | 24.79 |
Last price | $164.99 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
ESGU top holdings
| NVDA | NVIDIA Corp | 7.15% |
| AAPL | Apple Inc | 6.46% |
| MSFT | Microsoft Corp | 4.08% |
| GOOG | Alphabet Inc Class C | 3.54% |
| AMZN | Amazon.com Inc | 3.49% |
| AVGO | Broadcom Inc | 2.64% |
| GOOGL | Alphabet Inc Class A | 2.16% |
| MU | Micron Technology Inc | 1.98% |
| TSLA | Tesla Inc | 1.81% |
| META | Meta Platforms Inc Class A | 1.78% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About ESGU
ESGU (iShares MSCI USA ESG Optimized ETF) is US large/mid-cap stocks with favorable ESG ratings. Managed by iShares, the fund carries $17.7B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.94%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.1% of the portfolio. Real Estate is the fund's largest sector exposure at 2.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.